Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in Mice-Reference-Cited by-同舟云学术

Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in Mice

Published:2018-10-23 Issue:4 Volume:3 Page:e10084
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Alam Imranul¹²,Oakes Dana K¹,Reilly Austin M¹,Billingsley Caylin¹,Sbeta Shahed¹,Gerard-O'Riley Rita L¹,Acton Dena¹,Sato Amy²³,Bellido Teresita¹²³,Econs Michael J¹²⁴

Affiliation:

1. Department of Medicine; Indiana University School of Medicine; Indianapolis IN USA

2. Indiana Center for Musculoskeletal Health; Indiana University School of Medicine; Indianapolis IN USA

3. Department of Anatomy and Cell Biology; Indiana University School of Medicine; Indianapolis IN USA

4. Department of Medical and Molecular Genetics; Indiana University School of Medicine; Indianapolis IN USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbm4.10084/fullpdf

Reference32 articles.

1. Prevalence of oral glucocorticoid usage in the United States: a general population perspective;Overman;Arthritis Care Res (Hoboken),2013

2. Management of endocrine disease: secondary osteoporosis: pathophysiology and management;Mirza;Eur J Endocrinol,2015

3. Glucocorticoid-induced osteoporosis;Frenkel;Adv Exp Med Biol,2015

4. Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids;Warriner;Curr Opin Endocrinol Diabetes Obes,2013

5. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength;O'Brien;Endocrinology,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The osteocytic actions of glucocorticoids on bone mass, mechanical properties, or perilacunar remodeling outcomes are not rescued by PTH(1-34);Frontiers in Endocrinology;2024-07-18

2. Loss ofcped1does not affect bone and lean mass in zebrafish;2024-07-11

3. Multiple Mechanisms Explain Genetic Effects at the CPED1-WNT16 Bone Mineral Density Locus;Current Osteoporosis Reports;2023-03-21

4. Wnt16 signaling in bone homeostasis and osteoarthristis;Frontiers in Endocrinology;2022-12-22

5. Genetic variation in WNT16 and its association with bone mineral density, fractures and osteoporosis in children with bone fragility;Bone Reports;2022-06